Literature DB >> 35004967

Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference.

Zhiwen Luo1, Xinyu Bi1.   

Abstract

Entities:  

Year:  2021        PMID： 35004967      PMCID： PMC8683931          DOI： 10.21037/hbsn-2021-23

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  11 in total

1.  Liver Resection Improves Survival in Colorectal Cancer Patients: Causal-effects From Population-level Instrumental Variable Analysis.

Authors:  Mustafa Raoof; Sidra Haye; Philip H G Ituarte; Yuman Fong
Journal:  Ann Surg       Date:  2019-10       Impact factor: 12.969

2.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

3.  Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Authors:  Myrddin Rees; Paris P Tekkis; Fenella K S Welsh; Thomas O'Rourke; Timothy G John
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

Review 4.  American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.

Authors:  Sandra L Wong; Pamela B Mangu; Michael A Choti; Todd S Crocenzi; Gerald D Dodd; Gary S Dorfman; Cathy Eng; Yuman Fong; Andrew F Giusti; David Lu; Thomas A Marsland; Rob Michelson; Graeme J Poston; Deborah Schrag; Jerome Seidenfeld; Al B Benson
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

5.  Effects of multidisciplinary team on the outcomes of colorectal cancer patients with liver metastases.

Authors:  Xingchen Li; Qichen Chen; Xinyu Bi; Jianjun Zhao; Zhiyu Li; Jianguo Zhou; Zhen Huang; Yefan Zhang; Rui Mao; Hong Zhao; Jianqiang Cai
Journal:  Ann Palliat Med       Date:  2020-09-10

6.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

7.  Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy.

Authors:  Zhiwen Luo; Xiao Chen; Yefan Zhang; Zhen Huang; Hong Zhao; Jianjun Zhao; Zhiyu Li; Jianguo Zhou; Jianmei Liu; Jianqiang Cai; Xinyu Bi
Journal:  Front Cell Dev Biol       Date:  2021-01-28

8.  Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection.

Authors:  Qichen Chen; Rui Mao; Jianjun Zhao; Xinyu Bi; Zhiyu Li; Zhen Huang; Yefan Zhang; Jianguo Zhou; Hong Zhao; Jianqiang Cai
Journal:  Ann Transl Med       Date:  2021-02

Review 9.  Role of thermal ablation in the management of colorectal liver metastasis.

Authors:  Hideo Takahashi; Eren Berber
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

Review 10.  Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy.

Authors:  Heather A Lillemoe; Jean-Nicolas Vauthey
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.